Navigation Links
New Study Shows That Extending Prophylaxis With Clexane / Lovenox,(enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10,Days for Reducing the Risk of Venous Thromboembolism (VTE) in,Acutely ill Medical Patients With Reduced Mobility

cant 44% relative risk reduction in VTE events observed for extended-duration prophylaxis with enoxaparin vs. placebo for the primary endpoint (2.8% vs. 4.9%; p=0.0011) was associated with a reduction in symptomatic VTE by 73% (0.3% vs. 1.1%; p=0.0044) and asymptomatic proximal DVT by 34% (2.5% vs. 3.7%; p=0.0319). No statistically significant differences were observed for symptomatic pulmonary embolism (PE) or fatal PE. The statistically significant relative risk reduction of VTE observed with enoxaparin at 38 days was maintained at 90 days (3.0% vs. 5.2%; p=0.0015).

Victor F. Tapson, MD, Professor of Medicine, Director, Center for Pulmonary Vascular Disease, Division of Pulmonary and Critical Care, Duke University Medical Center, Durham, NC, and a lead investigator of the EXCLAIM study said :"What the trial results showed is that patients do not leave their risk for VTE at the door when they leave the hospital. With continued prophylaxis, Lovenox(R) statistically significantly reduced the risk by 44% in acutely ill medical patients with prolonged immobility."

In comparison with placebo, the rate of major bleeding was statistically significantly higher in the extended enoxaparin arm (0.6% vs. 0.15%, p=0.019), but the overall event rate was low. There was no difference in all-cause mortality between extended enoxaparin vs. placebo at 6 months (10.1% vs. 8.9%; p=0.18).

"EXCLAIM is the first study to assess the benefit of extended thromboprophylaxis in acutely ill medical patients with reduced mobility and to demonstrate the clinical benefit of 5 weeks enoxaparin treatment versus 10 days in this patient population" said Professor Russell Hull from the University of Calgary, Canada and Chair of the Steering Committee for the EXCLAIM study

"Similarly to the initial demonstration of the benefit of thromboprophylaxis for acutely ill medical patients, first established by the MEDENOX trial, the EXCLAIM study should be a landmark trial in advanci
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. Protox Announces Positive Clinical Data from Prostate Cancer Study
9. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
10. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
11. New Phase 3 Study Published in The Lancet Evaluates Efficacy and Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination Therapy in Treatment-Experienced Adults With HIV
Post Your Comments:
(Date:8/4/2015)... Aug. 4, 2015  Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL ... and six months ended June 30, 2015. ... are progressing and we continue to expect results in ... president and chief executive officer of Rigel. "We are ... programs, including evaluating fostamatinib for new treatment indications, as ...
(Date:8/4/2015)... FRAMINGHAM, Mass. , Aug. 4, 2015 ... a leading innovator of less invasive, miniaturized circulatory support ... failure, today announced that its President and Chief Executive ... at the Canaccord Genuity 35th Annual Growth Conference at ... conference is being held August 12-13, 2015 at the ...
(Date:8/4/2015)... , Aug. 4, 2015 Levi & ... Inc. ("Biogen" or the "Company") (NASDAQGS: BIIB) for possible ... Biogen and certain of its officers and/or directors have ... Act of 1934.  On Friday, July 24, 2015, prior ... second quarter 2015 financial results. Among other things, the ...
Breaking Medicine Technology:Rigel Announces Second Quarter 2015 Financial Results 2Rigel Announces Second Quarter 2015 Financial Results 3Rigel Announces Second Quarter 2015 Financial Results 4Rigel Announces Second Quarter 2015 Financial Results 5Rigel Announces Second Quarter 2015 Financial Results 6HeartWare Presentation At The Canaccord Genuity 35th Annual Growth Conference To Be Webcast 2SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation of Biogen Inc. and Its Board of Directors in Connection with Possible Violations of Federal Securities Laws -- BIIB 2
... Orthopedics This Week, the most widely read publication ... the winners of its 2010 Best Spine Technologies of ... and engineers for extraordinary innovation, hard work and effectiveness ... Winners were recognized at a gala awards ...
... each year on medical devices and equipment that are ... if purchased in the open-market according to a recent ... The study empirically shows that GPOs fail to deliver ... kickbacks from suppliers, and that they do not in ...
Cached Medicine Technology:Orthopedics This Week Announces 2010 Best Spine Technology Award Winners 2GPOs Fail to Provide Hospitals and Patients Health Care Savings 2
(Date:8/5/2015)... ... August 05, 2015 , ... " Wildflower Seed & Tool Company ... a look small, medium, and large businesses making an impact in their industry. Susan ... shared with viewers how their gardening tools are specifically designed for women. , With ...
(Date:8/5/2015)... ... August 05, 2015 , ... Available in select spas and at ... quartet of beauty-enhancing marine and plant oils. A perfect complement to Phytomer’s top selling ... out for its lovely scent and soothing properties. Formulated as a light and comfortable ...
(Date:8/5/2015)... ... August 05, 2015 , ... As the nation’s premier ... education and support in order to reduce the incidence of brain aneurysms and ... year it has awarded the most funding in the 20-year history of the ...
(Date:8/5/2015)... , ... August 05, 2015 , ... ... global clinical data standards. Members of global organisations such as PhUSE or CDISC ... such as the American FDA, the Japanese PMDA and the European EMA. A ...
(Date:8/4/2015)... ... August 05, 2015 , ... ... corporation, Crestwood Midstream, to store liquid propane gas (LPG) next to Seneca Lake*, ... workers union, unanimously passed a resolution that strongly opposes that permit. *, ** ...
Breaking Medicine News(10 mins):Health News:Wildflower Seed & Tool Company Design Gardening Tools Specifically for Women 2Health News:Phytomer launches ROSÉE SOIN Radiance Replenishing Oil 2Health News:Phytomer launches ROSÉE SOIN Radiance Replenishing Oil 3Health News:Phytomer launches ROSÉE SOIN Radiance Replenishing Oil 4Health News:Brain Aneurysm Foundation Awards Largest Amount of Research Funding at 9th Annual Brain Aneurysm Foundation Research Grant Awards Symposium Sept 10th in Houston, Texas 2Health News:Brain Aneurysm Foundation Awards Largest Amount of Research Funding at 9th Annual Brain Aneurysm Foundation Research Grant Awards Symposium Sept 10th in Houston, Texas 3Health News:Brain Aneurysm Foundation Awards Largest Amount of Research Funding at 9th Annual Brain Aneurysm Foundation Research Grant Awards Symposium Sept 10th in Houston, Texas 4Health News:Japan PMDA Publishes English Versions of Electronic Data Submission & Technical Conformance Guidance 2Health News:Japan PMDA Publishes English Versions of Electronic Data Submission & Technical Conformance Guidance 3Health News:Opposition Mounting to Permit Liquid Propane Gas Storage Next to New York’s Seneca Lake 2Health News:Opposition Mounting to Permit Liquid Propane Gas Storage Next to New York’s Seneca Lake 3
... containing benadryl linked to slowed thinking, delirium in ... News) --Older people taking common over-the-counter drugs for ... increase their risk for cognitive impairment, including delirium, ... include Benadryl, Dramamine, Excedrin PM, Nytol, Sominex, Tylenol ...
... healthcare IT company by revenue , , HATBORO, Pa., June ... IFLG ), a leading technology provider of enterprise mobility solutions for ... been named to Healthcare Informatics , ... , , (Logo: http://www.newscom.com/cgi-bin/prnh/20071101/NETH165LOGO ...
... Programs Give Seniors Helpful Solutions , , HOUSTON, ... nation,s largest non-profit organization for seniors, with over 500,000 ... Support & Financial and Retirement Planning. , , ... of resources to SCB members, with the goal of ...
... ... based clinic - The London Clinic. The contract marks the world,s first live site of ... ... leading provider of clinical workflow and integration technology for the health care sector world-wide, has ...
... Best ... minded individual. , ... London, England (PRWEB) June 5, 2009 -- Best Pills Inc is proud to announce ... ,The site is unique in its offering of popularly prescribed "discreet" prescription drugs ...
... PROVO, Utah, June 4 Nu Skin Enterprises, Inc. (NYSE: ... has declared a quarterly dividend of $0.115 per share, which ... record on June 15, 2009. , , The ... has been demonstrating its tradition of innovation through its comprehensive ...
Cached Medicine News:Health News:Some OTC Sleep, Cold Meds Could Harm Aging Brain 2Health News:Some OTC Sleep, Cold Meds Could Harm Aging Brain 3Health News:InfoLogix Named as One of the Top 50 Healthcare Information Technology Companies in the World 2Health News:InfoLogix Named as One of the Top 50 Healthcare Information Technology Companies in the World 3Health News:Senior Citizens Bureau Creates New Resourceful Divisions 2Health News:Orion Health Live at Harley Street Clinic 2Health News:Orion Health Live at Harley Street Clinic 3Health News:Bestpills Launchs its New Online Pharmacy 2
50L...
... and value!, Comfortable feel and ... contoured handle , Finer control while ... action , Completely autoclavable for easy ... for recalibration , Easy-to-read precision micrometer ...
... Pipette is a synonym for pipetting accuracy, ... design, and superior operating comfort. Its single, ... measuring stroke and blow-out as well as ... ensures utmost accuracy and precision. Ejection sleeve ...
250L...
Medicine Products: